111 related articles for article (PubMed ID: 15638060)
1. Active systemic lupus erythematosus successfully treated with Rituximab and oral steroid.
Armstrong DJ; Wright SA; Finch MB; Taggart AJ; Bell AL
Clin Exp Rheumatol; 2004; 22(6):787-8. PubMed ID: 15638060
[No Abstract] [Full Text] [Related]
2. Progressive multifocal leucoencephalopathy in a patient with systemic lupus erythematosus treated with rituximab.
Harris HE
Rheumatology (Oxford); 2008 Feb; 47(2):224-5. PubMed ID: 18045807
[No Abstract] [Full Text] [Related]
3. A case of rituximab-induced interstitial pneumonitis observed in systemic lupus erythematosus.
Kishi J; Nanki T; Watanabe K; Takamura A; Miyasaka N
Rheumatology (Oxford); 2009 Apr; 48(4):447-8. PubMed ID: 19202159
[No Abstract] [Full Text] [Related]
4. Early treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimen.
Ezeonyeji AN; Isenberg DA
Rheumatology (Oxford); 2012 Mar; 51(3):476-81. PubMed ID: 22096015
[TBL] [Abstract][Full Text] [Related]
5. Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus.
Kamiya K; Kurasawa K; Arai S; Maezawa R; Hanaoka R; Kumano K; Fukuda T
Mod Rheumatol; 2010 Feb; 20(1):81-5. PubMed ID: 19784542
[TBL] [Abstract][Full Text] [Related]
6. In lupus nephritis, the benefit of rituximab monotherapy, as opposed to rituximab plus cyclophosphamide combination therapy, remains uncertain: comment on the article by Sfikakis et al.
van Vollenhoven R; Gunnarsson I
Arthritis Rheum; 2005 Dec; 52(12):4050-1; author reply 4051-2. PubMed ID: 16320358
[No Abstract] [Full Text] [Related]
7. Hypocomplementemic urticarial vasculitis with angioedema, a rare presentation of systemic lupus erythematosus: rapid response to rituximab.
Saigal K; Valencia IC; Cohen J; Kerdel FA
J Am Acad Dermatol; 2003 Nov; 49(5 Suppl):S283-5. PubMed ID: 14576655
[TBL] [Abstract][Full Text] [Related]
8. Rituximab-responsive nephrotic syndrome due to minimal change disease in systemic lupus erythematosus.
Shahane A; Khasnis A; Gota C
J Clin Rheumatol; 2012 Jun; 18(4):199-202. PubMed ID: 22647855
[No Abstract] [Full Text] [Related]
9. A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus.
Tanaka Y; Yamamoto K; Takeuchi T; Nishimoto N; Miyasaka N; Sumida T; Shima Y; Takada K; Matsumoto I; Saito K; Koike T
Mod Rheumatol; 2007; 17(3):191-7. PubMed ID: 17564773
[TBL] [Abstract][Full Text] [Related]
10. Rituximab and lupus: good in real life, bad in controlled trials. Comment on the article by Lu et al.
Ramos-Casals M; Díaz-Lagares C; Khamashta MA
Arthritis Rheum; 2009 Sep; 61(9):1281-2. PubMed ID: 19714598
[No Abstract] [Full Text] [Related]
11. Management of therapy-resistant systemic lupus erythematosus with rituximab: report of a case and review of the literature.
Van den Bergh B; Selleslag D; Boelaert JR; Matthys EG; Schurgers M; Vandecasteele S; De Vriese A
Acta Clin Belg; 2005; 60(2):102-5. PubMed ID: 16082997
[TBL] [Abstract][Full Text] [Related]
12. Rituximab and lupus interstitial lung disease: friend or foe?
Efthimiou P; Kukar M; Hersh A
Int J Rheum Dis; 2011 Feb; 14(1):e3-4. PubMed ID: 21303472
[No Abstract] [Full Text] [Related]
13. Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.
So MW; Koo BS; Kim YJ; Kim YG; Lee CK; Yoo B
Mod Rheumatol; 2014 Sep; 24(5):855-7. PubMed ID: 24517558
[TBL] [Abstract][Full Text] [Related]
14. Immunologic reconstitution after rituximab in systemic lupus erythematosus: why should we care?
Anolik J
J Rheumatol; 2011 Apr; 38(4):587-9. PubMed ID: 21459953
[No Abstract] [Full Text] [Related]
15. Beneficial effects of rituximab therapy for systemic lupus erythematosus.
Menon S; Hari P; Bagga A
Indian J Pediatr; 2007 Jan; 74(1):79-82. PubMed ID: 17264461
[TBL] [Abstract][Full Text] [Related]
16. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.
Vallerskog T; Heimbürger M; Gunnarsson I; Zhou W; Wahren-Herlenius M; Trollmo C; Malmström V
Arthritis Res Ther; 2006; 8(6):R167. PubMed ID: 17092341
[TBL] [Abstract][Full Text] [Related]
17. Clinical, biological and ultrasonographic remission in a patient with musculoskeletal systemic lupus erythematosus with rituximab.
Torrente-Segarra V; Lisbona-Pérez M; Rotes-Sala D; Castro-Oreiro S; Carbonell-Abelló J
Lupus; 2009 Mar; 18(3):270-2. PubMed ID: 19213868
[TBL] [Abstract][Full Text] [Related]
18. The initial presentation of systemic lupus erythematosis with aplastic anemia successfully treated with rituximab.
Alishiri GH; Saburi A; Bayat N; Saadat AR; Saburi E
Clin Rheumatol; 2012 Feb; 31(2):381-4. PubMed ID: 22015937
[TBL] [Abstract][Full Text] [Related]
19. Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximab.
Simonetta F; Posa M; Villard J; Marceau-Renaut A; Preudhomme C; Samii K; Chizzolini C
Ann Hematol; 2015 Jul; 94(7):1247-9. PubMed ID: 25847363
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry.
Iaccarino L; Bartoloni E; Carli L; Ceccarelli F; Conti F; De Vita S; Ferraccioli G; Galeazzi M; Gatto M; Gerli R; Govoni M; Gremese E; Iuliano A; Mansutti E; Moroni G; Mosca M; Nalli C; Naretto C; Padovan M; Palma L; Raffiotta F; Roccatello D; Tincani A; Valesini G; Zen M; Doria A
Clin Exp Rheumatol; 2015; 33(4):449-56. PubMed ID: 26053285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
